Clinical trial
Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial
NCT03228030 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 2, 2018
- Completion date
- April 30, 2021
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congestive heart failure, heart failure, heart failure with reduced ejection fraction, thiamine deficiency